MARKET

APOP

APOP

Cellect Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.460
0.000
0.01%
Opening 12:32 12/10 EST
OPEN
2.530
PREV CLOSE
2.460
HIGH
2.540
LOW
2.460
VOLUME
11.90K
TURNOVER
--
52 WEEK HIGH
19.15
52 WEEK LOW
1.580
MARKET CAP
870.89M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of APOP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

APOP News

  • UPDATE: Cellect Biotechnology Q3 EPS $(0.12) Up From $(0.29) YoY
  • Benzinga.11/19 12:08
  • Cellect Biotechnology Reports Third Quarter 2019 Financial and Operating Results
  • PR Newswire.11/19 12:00
  • Cellect Biotechnology Q3 EPS NIS(0.42) Up From NS(1.04) YoY
  • Benzinga.11/19 11:18
  • Does Market Volatility Impact Cellect Biotechnology Ltd.'s (NASDAQ:APOP) Share Price?
  • Simply Wall St..11/11 11:29

More

Industry

Biotechnology & Medical Research
+0.65%
Pharmaceuticals & Medical Research
+0.69%

Hot Stocks

Name
Price
%Change

About APOP

Cellect Biotechnology Ltd, formerly Cellect Biomed Ltd, is an Israel-based company engaged in regenerative medicine through the development of products facilitating immune stem cell selection. The Company’s platform technology is based on the game changing perception that the functional properties of stem cells rather than appearance should be used for their identification, selection and utilization. The Company’s first product is designed to harness the critical function of sensitivity to specific apoptosis-inducing agents. While these molecules induce apoptosis (programmed cell death) in mature cells, they spare stem cells. This differential sensitivity is used to improve the outcome of bone marrow transplantation mainly by eliminating severe adverse effects.
More

Webull offers Cellect Biotechnology Ltd - ADR (APOP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.